Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk2009 | First Faculty of Medicine
- Individually aimed intervention beneficial in two-year hemodialysis patients survival and associated with decreased MCP-1 and increased HDL cholesterol2009 | First Faculty of Medicine
- Extracorporeal LDL-cholesterol elimination (25 years of experience in CZ)2009 | First Faculty of Medicine
- Therapeutic plasmapheresis and more specific methods of extracorporeal LDL-cholesterol elimination2009 | First Faculty of Medicine
- Hypolipidemic drugs and diabetes mellitus2009 | First Faculty of Medicine
- Cholesterol metabolism in active Crohn's disease2009 | First Faculty of Medicine
- Clinical impact of MIAC syndrom (malnutrition, inflammation, atherosclerosis, calcification) in patients with chronic renal disease2008 | First Faculty of Medicine
- Combined hypolipidemic treatment in jpatients with high cardiovascular (CV) risk2008 | First Faculty of Medicine
- Reological efect of extracorporeal elimination of LDL cholesterol in patient with peripheral arterial occlusive disease (PAOD) and diabetes mellitus (DM)2008 | First Faculty of Medicine
Loading network view...